Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Clementia Pharmaceuticals Inc. (CMTA): Are Hedge Funds Right About This Stock?

Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of September. At Insider Monkey, we follow over 700 of the best-performing investors and by analyzing their 13F filings, we can determine the stocks that they are collectively bullish on. One of their picks is Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), so let’s take a closer look at the sentiment that surrounds it in the current quarter.

Is Clementia Pharmaceuticals Inc. (NASDAQ:CMTA) an excellent investment right now? Investors who are in the know are in a pessimistic mood. The number of bullish hedge fund bets were cut by 1 recently. Our calculations also showed that CMTA isn’t among the 30 most popular stocks among hedge funds.

In the eyes of most traders, hedge funds are assumed to be slow, outdated financial vehicles of yesteryear. While there are over 8,000 funds in operation today, Our experts look at the upper echelon of this group, approximately 700 funds. These hedge fund managers oversee most of the hedge fund industry’s total capital, and by shadowing their inimitable picks, Insider Monkey has found a number of investment strategies that have historically outperformed the broader indices. Insider Monkey’s flagship hedge fund strategy outpaced the S&P 500 index by 6 percentage points per annum since its inception in May 2014 through early November 2018. We were able to generate large returns even by identifying short candidates. Our portfolio of short stocks lost 24% since February 2017 (through December 3rd) even though the market was up nearly 23% during the same period. We just shared a list of 11 short targets in our latest quarterly update.

Samuel Isaly Orbimed Advisors

We’re going to analyze the new hedge fund action encompassing Clementia Pharmaceuticals Inc. (NASDAQ:CMTA).

How are hedge funds trading Clementia Pharmaceuticals Inc. (NASDAQ:CMTA)?

At Q3’s end, a total of 10 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of -9% from the second quarter of 2018. By comparison, 14 hedge funds held shares or bullish call options in CMTA heading into this year. So, let’s find out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

CMTA_dec2018

The largest stake in Clementia Pharmaceuticals Inc. (NASDAQ:CMTA) was held by OrbiMed Advisors, which reported holding $116.2 million worth of stock at the end of September. It was followed by Baker Bros. Advisors with a $21.6 million position. Other investors bullish on the company included Driehaus Capital, Rock Springs Capital Management, and Partner Fund Management.

Because Clementia Pharmaceuticals Inc. (NASDAQ:CMTA) has experienced bearish sentiment from hedge fund managers, logic holds that there lies a certain “tier” of hedgies who were dropping their positions entirely last quarter. At the top of the heap, Anand Parekh’s Alyeska Investment Group cut the largest stake of the 700 funds followed by Insider Monkey, worth about $3 million in stock. D. E. Shaw’s fund, D E Shaw, also said goodbye to its stock, about $0.2 million worth. These moves are important to note, as aggregate hedge fund interest dropped by 1 funds last quarter.

Let’s now take a look at hedge fund activity in other stocks – not necessarily in the same industry as Clementia Pharmaceuticals Inc. (NASDAQ:CMTA) but similarly valued. These stocks are Landcadia Holdings, Inc. (NASDAQ:LCAHU), Preformed Line Products Company (NASDAQ:PLPC), Loop Industries, Inc. (NASDAQ:LOOP), and Capital Product Partners L.P. (NASDAQ:CPLP). All of these stocks’ market caps resemble CMTA’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
LCAHU 20 172318 2
PLPC 7 43442 3
LOOP 1 1627 0
CPLP 6 8793 0
Average 8.5 56545 1.25

View table here if you experience formatting issues.

As you can see these stocks had an average of 8.5 hedge funds with bullish positions and the average amount invested in these stocks was $57 million. That figure was $160 million in CMTA’s case. Landcadia Holdings, Inc. (NASDAQ:LCAHU) is the most popular stock in this table. On the other hand Loop Industries, Inc. (NASDAQ:LOOP) is the least popular one with only 1 bullish hedge fund positions. Clementia Pharmaceuticals Inc. (NASDAQ:CMTA) is not the most popular stock in this group but hedge fund interest is still above average. This is a slightly positive signal but we’d rather spend our time researching stocks that hedge funds are piling on. In this regard LCAHU might be a better candidate to consider a long position.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...